Clinical Trials Logo

Gastroesophageal Reflux clinical trials

View clinical trials related to Gastroesophageal Reflux.

Filter by:

NCT ID: NCT02685436 Completed - Clinical trials for Gastroesophageal Reflux Disease

Role of Pepsin Assay in Wheezy Infants

Start date: March 2013
Phase: Phase 4
Study type: Interventional

Wheezy infants were tested for gastro-esophageal reflux disease (GERD) using combined multiple channel intraluminal impedance-pH (MII-pH), esophagogastroduodenoscope (EGD), lipid laden macrophage index and BAL pepsin. Wheezy infants with abnormal MII-pH or reflux esophagitis were given domperidone and omeprazole then re-evaluated for symptoms control and exacerbations recurrence.

NCT ID: NCT02685150 Completed - Clinical trials for Gastroesophageal Reflux Disease

Endoscopic Tri-Modal Imaging to Distinguish Functional Dyspepsia From Reflux Disease

Start date: January 2016
Phase: N/A
Study type: Interventional

Endoscopic Tri-Modal Imaging which combines Narrow-band Imaging(NBI), Autofluorescence Imaging (AFI) and White-light Imaging (WLI) could be used to identify the indistinct changes in the gut caused by reflux disease,either acid reflux or bile reflux, which make it possible to differentiate reflux disease from functional dyspepsia (FD).

NCT ID: NCT02670642 Completed - Clinical trials for Gastroesophageal Reflux

Open, Randomised, Multi-center Study of on Demand Versus Continuous Esomeprazole Treatment in Patient With GERD

NEED
Start date: August 2001
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare on demand with continuous treatment of endoscopy negative subjects with gastroesophageal reflux disease (GERD), with esomeprazole 20-mg once daily, with regards to willingness to continue in the study as a result of satisfactory treatment over a six-month long term management period, after initial symptom relief.

NCT ID: NCT02637557 Completed - Clinical trials for Gastroesophageal Reflux Disease

A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD)

Start date: March 1, 2016
Phase: Phase 2
Study type: Interventional

The objectives of this study are to evaluate the safety, efficacy, and dose-response relationship of IW-3718 administered orally to participants who have GERD and continue to experience GERD symptoms while receiving once-daily (QD), standard-dose proton pump inhibitors (PPIs).

NCT ID: NCT02629081 Completed - GERD Clinical Trials

Image-Enhanced Endoscopy (IEE) for Diagnosis of Non-Erosive Reflux Disease

Start date: March 2015
Phase: N/A
Study type: Observational

When treating persistent heartburn from gastroesophageal reflux disease (GERD) that does not respond to conventional treatment (a class of medications called proton pump inhibitors), it is important to be able to distinguish between erosive GERD and non-erosive GERD (called NERD). Currently the best method the investigators have to make this distinction is esophageal 24-hour pH and impedance testing. The test involves inserting a catheter into the esophagus through the nose and having the catheter maintained in this position for 24 hours This test is invasive, can be uncomfortable, and it is expensive and time consuming. The investigators are hoping that image enhanced technology will identify characteristics that are found more commonly in patients with non-erosive GERD compared to controls and therefore provide evidence that may allow us to replace pH and impedance testing with the image enhanced endoscopy as the best way to diagnose NERD. Participants will be either patients undergoing an upper endoscopy as part of their standard clinical evaluation for heartburn that does not respond to PPIs or patients undergoing standard clinical evaluation endoscopy for other reasons.

NCT ID: NCT02623062 Completed - Clinical trials for Gastro-esophageal Reflux Disease (GERD)

Compound Sodium Alginate Oral Suspension Sachet Symptomatic Relief Study

Start date: December 2013
Phase: Phase 3
Study type: Interventional

This study is being conducted in China to provide evidence for inclusion in applications to competent authorities that the Compound Sodium Alginate Oral Suspension sachet is effective in managing the symptoms of heartburn and acid regurgitation in patients with gastro-esophageal reflux disease (GERD).

NCT ID: NCT02620241 Completed - Clinical trials for Gastro-oesophageal Reflux

Influence of Intrapulmonary Percussive Ventilation (IPV) on Gastro-oesophageal Reflux (GOR).

Start date: October 2015
Phase: N/A
Study type: Interventional

The study evaluates the effect on gastro-oesophageal reflux (GOR) of infants sitting in a stable upright position during 20 min. This is an addendum to the previous study with record number clinical trials.gov NCT02124863

NCT ID: NCT02618044 Completed - Obesity Clinical Trials

Laparoscopic Roux-en-Y Gastric Bypass and Gastro-esophageal Reflux

Start date: May 2006
Phase: N/A
Study type: Observational

Laparoscopic Roux-en-Y Gastric Bypass (LRYGB) is considered the weight loss procedure of choice for patients suffering of gastro-esophageal reflux (GER). However, long term instrumental evaluations of GER after LRYGB are not available. The aim of this study is to evaluate the long-term effects of laparoscopic Roux-en-Y Gastric Bypass (LRYGB) on gastro-esophageal function.

NCT ID: NCT02606851 Completed - Clinical trials for Patients With Typical Symptoms of GERD (GERD Q >= 8)

Proton Pump Inhibitor Empirical Treatment in Management of Outpatients With Gastroesophageal Reflux Disease.

Start date: December 4, 2015
Phase: N/A
Study type: Observational

China Survey of Proton Pump Inhibitor Empirical Treatment in Management of Outpatients with Gastroesophageal Reflux Disease

NCT ID: NCT02592902 Completed - Clinical trials for Recurrent Respiratory Papillomatosis

Recurrent Respiratory Papillomatosis and Extraesophageal Reflux

Start date: April 2014
Phase: N/A
Study type: Interventional

The purpose of the study was to determine, whether patients with recurrent respiratory papillomatosis (RRP) suffer from extra oesophageal reflux more often than patients with laryngeal cyst (control group).